About ARCT

Alcobra Ltd. is an emerging pharmaceutical company primarily focused on the development and commercialization of a proprietary drug candidate, MDX, to treat cognitive disorders including ADHD and FXS.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Biological Product (except Diagnostic) Manufacturing

ARCT is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
IWC iShares Microcap ETF 914.4 M 9.14374E+08 1,451 1451 0.01% 0.0001 90 K 89910

Wait, Before You Leave...